收藏切换
Advances in secondary metabolites produced by actinobacteria derived from animal-microbe mutualism and their biological activities
收藏切换
PDF
Fang-fang LI1, Sheng-sheng LU1, Teng-fei JI2, Jian HE1, *
Acta Pharmaceutica Sinica | 2017, 52(7) : 1091 - 1101
Less
收藏切换
Acta Pharmaceutica Sinica | 2017, 52(7): 1091-1101
REVIEWS
Advances in secondary metabolites produced by actinobacteria derived from animal-microbe mutualism and their biological activities
Full
Fang-fang LI1, Sheng-sheng LU1, Teng-fei JI2, Jian HE1, *
Affiliations
  • 1. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
  • 2. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2017-07-12 doi: 10.16438/j.0513-4870.2016-1220
Outline
收藏切换

Actinobacteria remain to be one of the major sources for new antibiotics, which historically play an essential role in human's fight against infectious diseases. Due to the emergence of resistant pathogenic microorganisms such as bacteria, fungi and viruses, it is imperative to develop new and effective drugs against these pathogens. The symbiotic actinobacteria residing inside the animals are becoming more and more important as a new source for drug discovery, as well as a "hotspot" in the field of microbial medicine. During the long period of evolution, a specific host-microbe mutualism is formed between the symbiotic bacteria and their hosts of animals. In this unique ecosystem, the secondary metabolites produced by bacteria are well tolerated by the hosts, meanwhile, are able to selectively suppress pathogenic microorganisms, thus providing a specific protection to their hosts. These secondary metabolites encompass a large variety of structural diversities of natural products, and so far, the reported biological activities are including antibacterial, antifungal, antiviral, antitumor, and immunomodulatory effects, which give them a great potential in the field of drug discovery. Herein, we review the secondary metabolites of animal symbiotic actinobacteria and their biological activities within the recent decade, by which to provide a viewpoint for future research of drug discovery from actinobacteria.

actinobacteria  /  secondary metabolites  /  biological activities  /  host-microbial mutualism
Fang-fang LI, Sheng-sheng LU, Teng-fei JI, Jian HE. Advances in secondary metabolites produced by actinobacteria derived from animal-microbe mutualism and their biological activities[J]. Acta Pharmaceutica Sinica, 2017 , 52 (7) : 1091 -1101 . DOI: 10.16438/j.0513-4870.2016-1220
Year 2017 volume 52 Issue 7
PDF
80
33
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2016-1220
  • Receive Date:2016-12-26
  • Online Date:2026-01-14
  • Published:2017-07-12
Article Data
Affiliations
History
  • Received:2016-12-26
  • Revised:2017-01-19
Funding
Affiliations
    1. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
    2. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2016-1220
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT